What is Regentys?
Founded in 2013 and headquartered in Miami Lakes, Florida, Regentys is a development-stage company focused on pioneering treatments for gastrointestinal disorders. The company's work in regenerative medicine aims to address unmet needs in patient care, positioning it as a key player in a specialized segment of the healthcare industry. The recent enterprise-level funding indicates a strong belief in its therapeutic pipeline and market potential.
How much funding has Regentys raised?
Regentys has raised a total of $1.5M across 1 funding round:
Private Equity
$1.5M
Private Equity (2016): $1.5M, investors not publicly disclosed
What's next for Regentys?
The substantial enterprise-level funding and recent strategic investment signal a critical growth phase for Regentys. This capital infusion is expected to accelerate the development and potential commercialization of its regenerative therapies for gastrointestinal conditions. The company is likely to focus on advancing its clinical trials, expanding its research and development capabilities, and potentially forging strategic partnerships to enhance its market reach and therapeutic impact.
See full Regentys company page
